News from sanofi pasteur A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Dec 27, 2021, 10:12 ET Importância do envolvimento de toda família na imunização: como pais e mães dividem a responsabilidade com a vacinação dos filhos?

Jul 26, 2016, 08:00 ET Sanofi Pasteur Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine)...

Jun 23, 2016, 07:56 ET New Four-Strain Influenza Vaccine, VaxigripTetra™, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe

New VaxigripTetra™ vaccine: A 4-strain influenza vaccine for people 36 months of age and older, Helps protect children, adults and seniors against...

Oct 20, 2015, 03:00 ET Un réseau international d'hôpitaux fait le bilan des formes sévères de la grippe saisonnière 2014-2015 lors de sa réunion annuelle

Oct 15, 2015, 11:00 ET Sanofi Pasteur and the Infectious Disease Research Institute Partner on a Global-Health, Open-Innovation, Vaccine Research & Development Center

Sanofi Pasteur, the vaccines division of Sanofi, announced today the creation of a Global Health Vaccine Center of Innovation (GHVCI) with the...

Jul 14, 2015, 08:00 ET Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in United States

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine)...

Mar 25, 2015, 12:15 ET Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has...

Dec 12, 2014, 08:00 ET Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...

Nov 03, 2014, 08:30 ET Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...

Sep 08, 2014, 02:14 ET FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA)...

May 19, 2014, 12:37 ET Sanofi Pasteur annonce des résultats encourageants pour l'essai de Phase II du candidat vaccin Clostridium difficile au congrès de l'ECCMID

May 19, 2014, 08:00 ET Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational...

May 12, 2014, 08:19 ET National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,1 a national survey revealed that more...

Apr 01, 2014, 09:13 ET Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has...

Mar 03, 2014, 01:00 ET Amplia disponibilidad de las vacunas antipoliomelíticas inactivadas para todos los niños del mundo en la iniciativa para la erradicación de la poliomielitis

Mar 03, 2014, 01:00 ET Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

Mar 03, 2014, 01:00 ET Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication

- Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable Inactivated Polio Vaccine (IPV) - Sanofi Pasteur, ...

Mar 03, 2014, 01:00 ET Amplia disponibilidad de las vacunas antipoliomelíticas inactivadas para todos los niños del mundo en la iniciativa para la erradicación de la poliomielitis

Mar 03, 2014, 01:00 ET Les enfants du monde entier vont pouvoir bénéficier du vaccin polio inactivé, dans le cadre de l'éradication de la poliomyélite

Feb 03, 2014, 03:00 ET Sanofi Pasteur lance une étude de phase III du vaccin candidat contre le Clostridium difficile en France